Trump reportedly wasn't pleased Mark Meadows publicly expressed concern about his health

President Trump continued to sound optimistic about his COVID-19 treatment Saturday evening in a video message from his suite at Walter Reed hospital in Bethesda, Maryland. Trump acknowledged he wasn't "feeling so well" when he first arrived at the hospital Friday, but added that he felt better at the time of the video. While he is expecting "a very good result" from his treatment, Trump said "over the next few days we're probably going to know for sure."
Trump's comments were more or less in line with a Saturday evening report from his physician, Navy Commander Dr. Sean Conley, who said he's "extremely happy" with the president's progress, noting that Trump received his second dose of the antiviral drug remdesivir. Trump is "not yet out of the woods," but the medical team "remains cautiously optimistic," Conley said in a statement.
Messaging from the White House wasn't always clear throughout Saturday, however, and questions about Trump's health remain. White House Chief of Staff Mark Meadows, for instance, told reporters Trump's vitals were "very concerning" on Friday, prompting doctors to give him supplemental oxygen before he left the White House for Walter Reed. Per Reuters, an anonymous Trump adviser said the president wasn't pleased when he learned about Meadows' remarks.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Meadows later phoned in to Fox News on Saturday evening, and reiterated to host Jeanine Pirro that Trump's blood oxygen level dropped "rapidly" on Friday, but he also expressed a lot of optimism about the president's condition this time around. Tim O'Donnell
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK Published
-
The battle for 21st century naturism laid bare
In The Spotlight Nudist lifestyle falling out of favour in Germany but naked attraction is on the rise in the UK
By Chas Newkey-Burden, The Week UK Published
-
The Week Unwrapped: Why do young people love ASMR?
Podcast Plus can US football stamp out homophobia? And why is Scottish Gallic getting a TV boost?
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published